Zynerba Pharmaceuticals Reports Third Quarter 2022 Financial Results and Operational Highlights
Ryan Allway November 14th, 2022 News, Top News Enrollment continues in RECONNECT, a confirmatory pivotal Phase 3 trial of Zygel™ in patients with Fragile X syndrome (FXS); topline results expected second-half 2023 $55.9 million in cash and cash equivalents at September 30, 2022; Cash runway into first quarter 2024... Read more
OPERATIONAL UPDATE AND COMPANY HIGHLIGHTS
Ryan Allway November 4th, 2022 News, Top News VANCOUVER, BC, Nov. 4, 2022 /CNW/ – YourWay Cannabis Brands Inc. (CSE: YOUR) (OTC: YOURF) (FSE: HOB) (the “Company” or “YourWay“), a consumer-centric House of Brands committed to redefining the way consumers and cannabis brands interact, is providing an operational update, including initiatives... Read more
Heritage Cannabis Reports 2021 Year-End Financial Results
Ryan Allway May 11th, 2022 News, Top News TORONTO, May 11, 2022–(BUSINESS WIRE)–Heritage Cannabis Holdings Corp. (CSE: CANN) (OTCQX: HERTF) (“Heritage” or the “Company“), today announced its financial results as at and for the twelve months ended October 31, 2021 (“FY 2021“). All figures are in Canadian dollars unless otherwise noted.... Read more
Generation Hemp Provides Operational Update
DALLAS, August 16, 2021–(BUSINESS WIRE)–Generation Hemp, Inc., a Dallas/Fort Worth based midstream hemp company (OTCQB: GENH) and its wholly-owned subsidiary, GENH Halcyon Acquisition, LLC (collectively the “Company”), today provided an operational update concerning new contracts recently awarded for its drying, cleaning, stripping, storage operations and other services based in... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )